Search Within

Gregory J Riely

  1. "Piro Lito"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (20)
  2. GSK Faculty (20)
  3. Human Oncology and Pathogenesis Program (20)
  4. Solid Tumor Oncology Division (20)
  5. Thoracic Oncology (20)
  6. Hematology-Oncology Fellows (18)

More Groups

People
  1. Piro Lito (20)
  2. Kathryn Arbour (16)
  3. Charles Rudin (13)
  4. Bob Li (11)
  5. Mark Kris (11)
  6. Marc Ladanyi (10)

More People

Years
  1. 2023 (3)
  2. 2022 (3)
  3. 2021 (6)
  4. 2020 (4)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Clinical Cancer Research (4)
  2. Journal of Clinical Oncology (3)
  3. Cancer Research (2)
  4. Nature Medicine (2)
  5. Annals of Oncology (1)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Clinical Oncology (4)
  3. Nature Publishing Group (4)
  4. Elsevier Inc. (2)
  5. Oxford University Press (2)
  6. Elsevier BV (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
    Journal Article

    Arbour, K. C.; Manchado, E.; Bott, M. J.; Ahn, L.; Tobi, Y.; Ni, A. A.; Yu, H. A.; Shannon, A.; Ladanyi, M.; Perron, V.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Journal Article

    Zhao, Y.; Murciano-Goroff, Y. R.; Xue, J. Y.; Ang, A.; Lucas, J.; Mai, T. T.; Da Cruz Paula, A. F.; Saiki, A. Y.; Mohn, D.; Achanta, P.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Ricciuti, B.; Rizvi, H.; Hellmann, M. D.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; Rudin, C. M.; Lito, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to KRAS G12C inhibition in cancer
    Meeting Abstract

    Awad, M.; Liu, S.; Arbour, K.; Zhu, V.; Johnson, M.; Heist, R.; Patil, T.; Riely, G.; Jacobson, J.; Dilly, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Acquired resistance to KRAS(G12C) inhibition in cancer
    Journal Article

    Awad, M. M.; Liu, S.; Rybkin, I. I.; Arbour, K. C.; Dilly, J.; Zhu, V. W.; Johnson, M. L.; Heist, R. S.; Patil, T.; Riely, G. J.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save